cell therapies

News

Martin Olin has been named chief executive of the UK start-up

UK biotech Swarm lands with a T-cell therapy mission

UK firm Swarm Oncology launches with a T-cell therapy platform to treat solid tumours, with a Resolution Therapeutics co-founder in the pilot seat.

News

Galapagos' chief executive Paul Stoffels

Galapagos unveils plan to split, hiving off its drugs unit

Belgian biotech Galapagos is mixing things up again via a plan to split in two, separating its drug development and cell therapy operations.

News

CARsgen gets a win for CAR-T in solid tumours

CARsgen Therapeutics' claudin 18.2-targeting autologous CAR-T therapy satri-cel has shown efficacy in gastric cancer, setting up a filing in China.

News

Capricor files cell therapy for DMD cardiomyopathy with FDA

Capricor completes its US filing for deramiocel, vying to become the first FDA-approved therapy for cardiomyopathy in Duchenne muscular dystrophy.

Oncology

Transforming autoimmune disease therapy: Post-ACR 2024 persp...

The 2024 American College of Rheumatology (ACR) annual meeting spotlighted transformative advancements in cell therapies for autoimmune diseases, with chimeric antigen receptor (CAR)-T ther

News

Medigene axes staff and refocuses its TCR pipeline

Medigene slashes staff and delays trials of its lead TCR therapy candidate as it refocuses its pipeline

UK biotech Swarm lands with a T-cell therapy mission

Galapagos unveils plan to split, hiving off its drugs unit

CARsgen gets a win for CAR-T in solid tumours

Capricor files cell therapy for DMD cardiomyopathy with FDA

Transforming autoimmune disease therapy: Post-ACR 2024 persp...

Medigene axes staff and refocuses its TCR pipeline

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

cell therapies

Editor's Picks